US2003211037A1PendingUtilityA1
Determining effects of external stimuli on the brain using PET
Priority: Sep 1, 1995Filed: Apr 14, 2003Published: Nov 13, 2003
Est. expirySep 1, 2015(expired)· nominal 20-yr term from priority
A61B 6/507A61K 51/0491A61B 6/037A61B 6/508
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of evaluating the effects of administering an external stimuli or treatment such as a psychoactive compound, a drug, or an environmental influence like temperature, noise, vibration, light and similar sensory-perceived influences, on a subject's brain using imaging techniques with position emission tomography (PET). The method measures cerebral metabolism before and after administering the external stimuli or treatment, and employs a behavioral clamp to control behavioral influences on the subject's brain after administration of the external stimuli or treatment.
Claims
exact text as granted — not AI-modifiedIn the claims:
1 . A method for comparing unknown pharmaceutical compounds with known pharmaceutical compounds, the method comprising:
(a) using positron emission tomography to measure cerebral metabolism of a subject's or patient's brain prior to any treatment with an unknown pharmaceutical compound; (b) administering the unknown pharmaceutical compound to a subject or patient; (c) controlling behavioral influences on the subject or patient; (d) using positron emission tomography to measure cerebral metabolism of the subject's or patient's brain after administering the unknown pharmaceutical compound to the subject or patient while controlling behavioral influences on the subject's or patient's brain; and (e) comparing the cerebral metabolism of the subject or patient while exposed to the unknown pharmaceutical compound with the cerebral metabolism of the same or different subjects or patients while exposed to known pharmaceutical compounds.
2 . The method of claim 1 , wherein behavioral influences are controlled with a behavioral clamp.
3 . The method of claim 2 , wherein the behavioral clamp comprises a visual monitoring task (VMT).
4 . The method of claim 1 , further comprising the step of measuring the subject's or patient's mood both before and after administering the compound.
5 . The method of claim 4 , wherein the step of measuring a subject's or patient's mood comprises administering a standard psychological test to the subject or patient.
6 . The method of claim 5 , wherein the standard psychological test is a profile of mood states (POMS).Join the waitlist — get patent alerts
Track US2003211037A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.